Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine/Cetylpyridinium vs Probiotic in Periodontal Disease and Type 2 Diabetes
NCT07489924Phase 4Active, not recruiting
- Sponsor
- Universidad de Colima
- Start
- Jan 2023
- Primary completion
- Jul 2025
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of L. reuteri Prodentis in periodontal disease, sponsored by Universidad de Colima. Started Jan 2023; status: active, not recruiting.
02
Drugs
L. reuteri Prodentis
03
Conditions
periodontal disease
Beyond the preview
Go deeper on NCT07489924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07489924.